
Nikethamide250 mg/ml
Jayson Pharma Ltd.
Nikethamide is an older-generation respiratory and central nervous system (CNS) stimulant (analeptic agent).
Nikethamide is an older-generation respiratory and central nervous system (CNS) stimulant (analeptic agent). Its clinical use has substantially declined and it has been superseded in most modern healthcare settings by mechanical ventilation, targeted reversal agents (e.g., naloxone, flumazenil), and advanced respiratory monitoring.
Nikethamide is not considered a first-line or routine therapy in contemporary practice because of its narrow margin between an effective dose and a dose that causes toxicity (including seizures). Where available, it should be reserved for use by trained medical personnel with continuous monitoring, and only when definitive respiratory support (e.g., mechanical ventilation) is not immediately available.
Nikethamide is intended for administration only by trained healthcare professionals in a monitored clinical setting (e.g., hospital or emergency department), because of its narrow margin between an effective and a toxic dose.
| Indication | Population | General Dosing Approach |
|---|---|---|
| Respiratory depression (e.g., anesthetic or CNS depressant-induced) | Adults | Administered by slow intravenous or intramuscular injection by a physician; the dose and frequency are individualized based on the patient's clinical response, vital signs, and continuous monitoring for signs of CNS overstimulation. Repeat dosing, if required, is guided entirely by clinical response. |
| Respiratory depression | Pediatric patients | Use in children is generally avoided in current practice; safety and efficacy have not been established, and alternative, safer interventions are preferred (see Pediatric Use). |
| Renal or hepatic impairment | All ages | No well-established dose adjustment has been defined; use with added caution and closer monitoring, as impaired clearance may increase the risk of toxicity. |
Because of the risk of serious adverse effects with excessive or repeated dosing, Nikethamide should never be self-administered and should only be given under direct physician supervision with resuscitation facilities available.
Because of the narrow margin between the effective dose and the dose causing these serious effects, Nikethamide requires close clinical monitoring during use.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.